
H 7706 (see companion bill S 2535) – Rhode Island
Status: Inactive / DeadYear Introduced: 2018
Link: http://webserver.rilin.state.ri.us/BillText/BillText18/HouseText18/H7706.pdf
THE PRESCRIPTION DRUG SALES REPRESENTATIVE DISCLOSURE ACT: Requires prescription drug manufacturers to file a detailed, updated list of each pharmaceutical sales representative and to pay an annual fee for each name listed with the department of business regulation.
Key Issues:
PHARMACEUTICALS
Return to Database Search
© 2018- The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.
Associated Litigation:
No items found
Leave A Comment